107 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, including those relating to patient privacy; determinations by regulatory and administrative governmental authorities which may delay or restrict
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy
8-K
EX-99.1
2kmdn4nzfey7
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
ix2e7lf n74xuf
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
EX-99.1
spc ped2m4b
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
e4od250rabt9o943
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
8-K
EX-99.1
nyh0aikzpmza2v8
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
8-K
EX-99.1
jni 07fkz
3 Aug 22
Regeneron Reports Second Quarter 2022 Financial and Operating Results
7:08am
SC TO-T/A
EX-99
4rxq2rx
31 May 22
Third party tender offer statement (amended)
8:38am